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Background: We present the case of a patient with adenoid cystic carcinoma of the
trachea who had 60 mm of the trachea excised and reconstructed with a stented
radial forearm free flap. The patient was well in the immediate postoperative period
with good function of the neotrachea. Problems developing after the reconstruction
included proximal stricture, sputum retention, and recurrent pneumonia.
Result: The patient died of malignant hypercalcemia 16 months after the recon-
struction. To our knowledge this is the first reported case of a total tracheal resection
and reconstruction with a combination of free tissue transfer and internal stenting.
Conclusion: We conclude that tracheal reconstruction has the potential to provide a
reliable airway in patients not able to be reconstructed with a primary anastomosis.
We report a case of adenoid cystic carcinoma of the tracheathat was resected and the trachea reconstructed with a tubedradial forearm free flap (RFFF) supported by Ultraflex stents(Boston Scientific, Boston, Mass). According to Azar, Ab-dul-Karim, and Tucker,1 the first reported case of adenoidcystic carcinoma was in 1762 by Morgagni. Billroth, as cited
by Pearson and associates,2 first described the characteristics and pathology of
adenoid cystic carcinoma in 1859. Ever since then, tracheal tumors have provided
a diagnostic and treatment challenge. Tracheal tumors are uncommon, with an
estimated incidence of 2.7 new cases per million per year.3 The majority of these
patients have progressive dyspnea, wheeze, and/or persistent cough, which is often
initially misdiagnosed as asthma or bronchitis. It is not until late in the course of the
illness that other symptoms such as stridor, hemoptysis, dysphagia, or hoarseness
raise the possibility of an obstructive lesion.1,4 Tracheal tumors present a diagnostic
challenge because of their rarity and nonspecific symptoms. When the tracheal
tumor is eventually discovered, it has usually nearly occluded the trachea and the
possibility of cure is severely reduced. Tracheal tumors can be divided into 3 major
groups; adenoid cystic carcinoma, squamous cell carcinoma, and miscellaneous.
Adenoid cystic carcinoma accounts for 30 to 40% of tracheal tumors and has some
distinct features.
Adenoid cystic cancer is a locally invasive tumor that has a long progressive
course. It is the second most common malignant salivary gland tumor. Local
recurrence is usually the cause of death. Pulmonary metastases are most common,
but metastases to brain, bone, liver, skin, kidney, abdomen, and heart have been
described.1 Macroscopically, it appears as a circumferential nodule with a smooth
surface. The macroscopic appearance is quite deceptive, and it usually extends far
beyond the macroscopic limit. The only treatment that is effective is surgical
resection with radiotherapy having only an adjuvant role. Even if the cancer is
From Cardiothoracic Surgery,a Department
of Otolaryngology—Head and Neck Sur-
gery,b Department of Plastic and Recon-
structive Surgery,c Anaesthetics,d and Tho-
racic Medicine,e St Vincent’s Hospital,
Sydney, Australia.
Received for publication Jan 4, 2003; ac-
cepted for publication Jan 22, 2002.
Address for reprints: Dr Bernard Richard
Beldholm, St Vincent’s Hospital, PO Box
689, Miranda NSW 1490, Australia (E-
mail: Beldholm@yahoo.com).
J Thorac Cardiovasc Surg 2003;126:545-50
Copyright © 2003 by The American Asso-
ciation for Thoracic Surgery
0022-5223/2003 $30.00  0
doi:10.1016/S0022-5223(03)00357-X
Beldholm et al General Thoracic Surgery
The Journal of Thoracic and Cardiovascular Surgery ● Volume 126, Number 2 545
G
TS
incompletely excised, prolonged palliation can be
achieved.1 Local recurrences can occur many years later,
and recurrences after 10 to 15 years have been reported.
Therefore, long-term follow-up is required.
Once the tracheal tumor has been diagnosed, a decision
has to be made as to what treatment can be offered. A
number of case series with resection and primary anasto-
mosis have demonstrated a good success rate, with good
palliation or cure. The only real possibility of cure in a
tracheal cancer is surgery, because radiotherapy is not cur-
ative. Extensive circumferential defects up to 50% and in
rare instances larger defects can be closed primarily. Mo-
bilization and suprahyoid release of the larynx may be
required. Reconstruction of extensive circumferential tra-
cheal defects with autologous tissue has until now proved
beyond surgical possibility. For the patient requiring total
surgical resection of the trachea for tumor clearance, tra-
cheal prostheses or mediastinal tracheostomy represent less
than satisfactory methods for maintaining airway continu-
ity. We present the first reported case to our knowledge of
total tracheal resection and reconstruction using a combina-
tion of autologous free tissue transfer and internal stenting.
Case Study
A 43-year-old woman had increasing respiratory distress
over 9 weeks. She had difficulty with inspiration. Symptoms
were worse at night, when lying down, and at rest. On
examination she had marked inspiratory and expiratory
stridor, with widespread expiratory wheezes on ausculta-
tion. Examination did not show lymphadenopathy or hepa-
tosplenomegaly. Lack of response to initial treatment for
asthma led to the performance of chest computed tomogra-
phy (CT), which revealed near complete obstruction of the
trachea by a polypoid mass.
Examination with a rigid bronchoscope showed a 1- to
2-cm mass 3 cm from the carina (Figure 1). Laser debulking
was undertaken and a Dumon (Novatech, Aubagne, France)
stent inserted. Histologic study showed an adenoid cystic
carcinoma with high-grade areas. The patient had marked
relief of her symptoms from this initial procedure.
Before the planned definitive operation, the patient un-
derwent mediastinal endoscopic ultrasound, positron emis-
sion tomography (PET), and a chest CT scan. Endoscopic
ultrasound showed a normal mediastinum, no nodal in-
volvement, and no sonographic features of esophageal wall
infiltration. CT showed the tracheal tumor involving 3 to 4
cm of the midtrachea. PET scanning demonstrated no met-
astatic disease. Bronchoscopy before the operation con-
firmed that there was no macroscopic evidence of tumor
involving the upper and lower margins of the trachea.
Operation
The operation was carried out in 4 phases:
1. Upper tracheal mobilization and RFFF harvest, supine
with double lung ventilation.
2. Right thoracotomy, tracheal resection, neotrachea
placement, and intubation, decubitus with left single
lung ventilation.
3. Neotrachea microvascular anastomosis, neck closure,
and split skin graft from thigh, supine with left single
lung ventilation.
4. Thoracotomy closure and skin graft to arm, decubitus
double lung ventilation.
The Dumon stent (Bryon Corp, Woburn, Mass) was too
small to admit a double-lumen endotracheal tube, so a
single-lumen size 6 armored endotracheal tube was passed
into the conventional position for double lung ventilation
and then passed into the left main bronchus for left single
lung ventilation.
Phase 1. A utility neck flap was raised and the strap
muscles separated. The trachea was then exposed in the
neck and mobilized with preservation of the recurrent la-
ryngeal nerve. Simultaneously, the left RFFF was mobilized
and a flap of skin 13 by 6.5 cm was elevated. The flap was
raised by standard techniques and the radial artery divided
at the distal end of the wrist. The cephalic vein and deep
communicating veins were harvested to the cubital fossa. A
5-mm border around the flap was deepithelialized for tubing
at the distal and proximal anastomosis. The flap was then
tubed around the Ultraflex stent (Boston Scientific Co, Bos-
ton, Mass) with continuous 4-0 Monocryl suture (Ethicon,
Inc, Somerville, NJ).
Phase 2. The patient was rolled left side down and the
chest entered through a posterolateral thoracotomy in the
right fourth intercostal space. The single-lumen tube was
advanced from the trachea into the left main bronchus for
single lung ventilation. The intrathoracic trachea was then
Figure 1. Tracheal tumor before debulking and definitive
operation.
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mobilized by dividing the azygos vein and the vagus nerve.
The distal trachea was divided and the left main bronchus
directly cannulated via the thoracotomy while the endotra-
cheal tube was withdrawn into the larynx. Single lung
ventilation was continued in this fashion while the remain-
der of the trachea was then mobilized from above and
below. The trachea was excised 2 rings below the cricoid
and 1 ring above the carina. Frozen section of the proximal
ring was clear of tumor but the distal ring was not, so the
remaining distal ring was excised and was disease free on
frozen section.
The neotrachea was transferred into the thorax and the
pedicle divided and delivered into the neck, ensuring no
torsion. The proximal and distal anastomoses were com-
menced, and the posterior wall or membranous trachea was
sutured to the neotrachea with 3-0 Prolene continuous su-
tures (Ethicon). The Ultraflex stent was flush with and
partially incorporated in the distal anastomosis. There was a
3- to 4-mm gap between the proximal anastomosis and the
Ultraflex stent, which had to be covered by a second Ultra-
flex stent deployed from below to cover the gap and allow
the endotracheal tube to be advanced via the neotrachea into
the left main bronchus. The anterior wall of the distal and
proximal tracheal anastomoses was then completed. The
thoracotomy wound was covered with an OpSite dressing
(Smith & Nephew, London, United Kingdom) and the pa-
tient rolled back to the supine position.
Phase 3. Microvascular anastomoses were performed
with 8-0 monofilament nylon interrupted sutures and micro-
vascular staples (medium; Auto Suture Company Division,
United States Surgical Corporation, Norwalk, Conn.). The
radial artery was joined to the external carotid artery as an
end-to-side anastomosis and the deep and superficial veins
of the flap to the internal jugular vein as an end-to-side
anastomosis. The strap muscles closed anteriorly in front of
the anastomosis. A single Jackson Pratt drain was placed in the
neck and the remainder of the neck wound closed in layers. A
split skin graft was then harvested and the radial forearm donor
site was split skin grafted and supported with a back slab.
Phase 4. The patient was then rolled left side down
again and the thoracotomy wound explored. The single-
lumen tube was withdrawn back up into the distal trachea;
the anastomosis was airtight and tested for leaks with warm
water. The pedicle was pulsing nicely and the tracheal
conduit appeared well vascularized. Two chest drains were
placed and the thoracotomy wound closed with pericostal
and subcuticular sutures. The patient was rolled supine and
the single-lumen tube exchanged for a larger tube allowing
bronchoscopy and tracheobronchial direct suction (Figure 2).
Comment on the Operation
The 2 Ultraflex stents used were uniquely suitable for this
reconstruction and probably no other commercially avail-
able stent would have functioned as well. The 2 stents were
used as a backbone for the reconstruction and were sutured
together to provide optimal function. The use and properties
of this stent are further discussed below.
Histologic examination showed an adenoid cystic carci-
noma 40 mm in length and a maximum thickness of 10 mm.
On the initial specimen the tumor was 9 mm from the
proximal margin with the distal margin involved; after
further excision the distal margin was cleared. In total there
were 12 lymph nodes in the specimens sent to pathology
and they were all confirmed to be clear of tumor.
Postoperative Course
The patient was extubated at the end of the procedure after
the placement of an epidural catheter afforded good anal-
gesia and respiratory function. The patient was mobilized
the following day and the chest drains removed on postop-
erative days 2 and 3. Respiratory function was maintained
with aggressive physiotherapy and analgesia despite some
early problems with atelectasis and sputum retention.
The initial bronchoscopic examination showed good
healing of the anastomoses and remarkably good function of
the neotrachea, especially during coughing when partial
tracheal closure mimicked the physiology of the native
trachea. The patient was well and discharged with only a
minor nonproductive cough.
The patient returned for bronchoscopic examination 1
month after the operation. At this stage a cough productive
of red-brown sputum had developed. Sputum sample
showed Staphylococcus aureus. Bronchoscopy demon-
strated multiple areas of granulation tissue growing into the
Figure 2. Distal view of anastomosis with the Ultraflex stent in
situ and showing the suture line and the carina.
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trachea from the flap covering the stent (Figure 3). Granu-
lation tissue was cauterized and resected at this session. The
patient was discharged in good health the next day.
Postoperative radiotherapy was commenced 40 days af-
ter the reconstruction. A total of 52 Gy was delivered in 26
fractions to the mediastinum and lower parat of the neck.
She had mild esophagitis, right neck pain associated with
swallowing, and a mild erythematous skin reaction of the
lower neck, all of which resolved.
During the year after the operation, the patient was well
but continued to have a persistent dry cough. A subglottic
stricture (Figure 4) also developed just above the stent,
which had to be dilated on multiple occasions. Broncho-
scopic examinations were performed every 5 to 6 weeks.
There were multiple admissions for S aureus pneumonia
and she had problems with sputum plugging culminating in
1 episode of respiratory arrest necessitating intubation.
Severe pain in her left shoulder also developed, neces-
sitating high-dose narcotics. PET scan showed an infiltra-
tive process in both lungs thought likely to represent an
inflammatory disease rather than malignancy. Bone scan
demonstrated uptake in the right ischium, superior sacrum,
thoracic lumbar spine, T3, T10 vertebrae, and fifth, sixth,
and tenth ribs. A left pleural effusion developed, but cyto-
logic examination did not demonstrate malignant cells. Six-
teen months after the initial operation, she was admitted to
the hospital with increasing bone pain predominantly in the
midthoracic and shoulder regions, increasing dyspnea, and
increasing malaise. She had marked weight loss, hypercal-
cemia, and anemia. Chest radiography showed a diffuse
infiltrate throughout the left lung. In consultation with the
family and patient, the decision was made that further
invasive ventilatory support was not appropriate. Her respi-
ratory status progressively deteriorated and she died shortly
thereafter. An autopsy was not performed.
Discussion
Tracheal tumors are uncommon and there has therefore
been a slow progression in the treatment and management
of these tumors. The best option for managing these tumors
is surgical resection. Before the 1960s it was believed that
only 2 cm of the trachea could be resected and primary
anastomosis achieved, but with new techniques it is today
possible to resect in some instances more than 50% of the
trachea and still obtain primary anastomosis.4-6 Beyond
these limits it is necessary to replace the trachea with a
prosthesis. This remains a therapeutic challenge.
The trachea is a perfectly constructed organ ideally
suited for its functional demands. It is a rigid airtight struc-
ture that can vary its diameter for optimal conduction of air,
it has the ability to clear secretions, and it senses any foreign
material. As with any organ, prostheses or reconstructions
can only crudely match what nature has constructed. An
ideal tracheal prosthesis should have lateral rigidity, vertical
flexibility, an airtight lumen, reliable healing, and a contin-
uous lining with respiratory epithelium.7 So far, no method
or material has been described for fulfilling all these re-
quirements.
Recently Grillo8 did an extensive review of tracheal
replacement with artificial and autologous materials; this
review concludes that there has been a very poor success
rate so far. Constructing a functional tracheal conduit that
provides good function with minimal complications has
proven difficult, as can be attested by the wide range of
materials used in the attempts. So far a high mortality and
morbidity rate has been apparent in all tracheal prosthetic
reconstructions, although some of the individual experimen-
tal studies hold promise.
Figure 3. Exuberant granulation tissue growing in through the
stent postoperatively.
Figure 4. Postreconstruction view of the trachea showing the
proximal stenosis.
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Initially foreign materials were used, such as stainless
steel, steel coils, silicone, Teflon, and Marlex mesh. These
replacements had a number of serious problems. They were
not incorporated into the local tissues; they migrated, dis-
lodged, got infected, and became obstructed. A particular
problem was the formation of granulation tissue at the
anastomosis, which would lead to stenosis and obstruction.
The trachea is not a sterile structure and so infections tended
to develop around the anastomosis. These materials where
also very stiff, which meant that they would erode into the
surrounding structures and a high mortality rate from bra-
chiocephalic artery ruptures were noted early on. Early
reports of replacement with Marlex mesh would have a
mortality rate of up to 70% in the early postoperative
period.2,5,9 So far the majority of trials with foreign mate-
rials have had poor results.8
In an attempt to overcome the problems of nonepitheli-
alization, granulation tissue formation, and migration of the
conduit, trials have been conducted with porous materials as
well as cadaveric nonviable tissues. Trials both in human
subjects and in animals have shown that excessive granu-
lation tissue leads to stenosis, and the need for frequent
bronchoscopic treatments has been a continuing prob-
lem.8,10 Some apparent experimental success has been
achieved with the porous type of tracheal prosthesis,10,11
where variable lengths of conduits were incorporated into
animals with reepithelialization occurring in the majority of
cases. These materials have yet to have any impact in
human studies.
It is recognized that autologous tissue provides better
blood supply and primary healing, especially in areas with
previous surgery or irradiation. The difficulty with recon-
structing a circumferential tracheal defect has been to de-
sign a flap with intrinsic or added rigidity to prevent inward
collapse, stenosis, or obstruction. A number of animal stud-
ies have been performed to investigate the feasibility of total
tracheal reconstruction using autologous tissue. Jones and
colleagues12 and Nakayama13 have reported the use of a
free jejunal microvascular flap to reconstruct both noncir-
cumferential and circumferential tracheal defects in a canine
model. The main disadvantages of these flaps are their lack
of rigidity and excessive mucous secretion. Nakayama then
added an intraluminal silicone T tube to provide support and
showed that cauterization of the mucosa successfully re-
duced mucous secretion.
A large number of different free grafts have been used
for tracheal replacement, ranging from omentum, perichon-
drial slips, and bladder mucosa to dura mater.8 These free
grafts have been supported by an equally large number of
supports from silicone tubes to prefabricated cartilage rings.
In the experience to date none of these has had lasting
success. Multistage cutaneous tubes have been used to re-
construct the cervical trachea, but high mortality and mor-
bidity rates were noted. Obtaining an airtight seal immedi-
ately was also not possible and so reconstruction of the
intrathoracic trachea would be difficult. A number of other
authors14,15 have attempted to prefabricate flaps with carti-
lage grafts and skin grafts for lining before transfer. In a
recent study by Cavadas16 using a goat model, a composite
cutaneous chondromucosal premolded, prevascularized flap
was reconstructed in a 2-staged procedure with subsequent
microvascular transfer. In this case, the entire trachea was
reconstructed with autologous cartilage and nasal mucosal
grafts around a silicone stent implanted into a thigh. The
stent was then removed before transfer, creating a total
autologous neotrachea. In this study only 30% of the ani-
mals survived. The main disadvantage with prefabrication
techniques is that they are multistaged and would be diffi-
cult to apply in the clinical setting.
From the above discussion it is apparent that a new
approach to tracheal replacements needs to be taken. There
has been previous experience in using RFFF to reconstruct
in part the trachea and the esophagus. Wheatley and col-
leagues17 used an RFFF to elongate the trachea so as to
construct a neotracheostome after resection of recurrent
stomal tumors. Four patients were treated by this technique
and had a good postoperative course, with none having
stomal narrowing or strictures. One patient had venous
thrombosis in the graft, which was treated successfully, and
subsequently did well. The longest follow-up available in
this series is a patient at 38 months after reconstruction who
is still doing well. RFFF for pharyngoesophageal recon-
structions was described in 1985.18 Since then a large num-
ber of patients have been treated with this reconstruction
with a good success rate. For relevance to tracheal recon-
structions, the RFFF has been found to be a highly reliable
flap, there is limited donor site morbidity, and a long vas-
cular pedicle is available.18
The concept of combining an RFFF with an internal stent
in tracheal replacements has not, to our knowledge, been
previously attempted. The rationale for using a skin lining is
that it would be more robust and able to withstand sheer and
abrasion from the stent. This model satisfies almost all of
Belsey’s criteria for the reconstructed trachea. It provides
lateral rigidity, vertical flexibility, and remarkable physio-
logic compression for clearance of sputum as seen on bron-
choscopic examination.
The purpose of the stent in this reconstruction was to
provide stability and a patent airway. Other properties that
were necessary were lateral flexibility and for the stent not
to migrate. It was also important that the stent be able to
return to its original shape after being deformed for the
reconstruction to work. The Ultraflex stent has all of the
necessary properties and was uniquely suitable for use in
this reconstruction, as compared with stainless steel stents
such as the Gianturco-Z stent and the Wallstent and silicone
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stents such as the Dumon stent. These properties include
superelasticity, shape memory, biocompatibility, kink resis-
tance, and fatigue resistance.19 It provides a larger diameter
for the airway as compared with the Dumon stents, and also
if uncovered provides the opportunity for respiratory epi-
thelium to be reformed.19 The Ultraflex stent is a self-
expanding stent constructed out of nickel-titanium alloy
(nitiniol); when released it contracts in length by 27% to
40%.20 Nitiniol has the property of superelasticity and shape
memory. Superelasticity refers to the ability of nitiniol to be
deformed up to 10% to 12% and still regain its original size
and shape; stainless steel can only tolerate a deformation of
up to 0.5% before changing shape permanently. Shape
memory refers to the ability of the device to restore its
original configuration in a specific temperature range.21 The
function of the Ultraflex stent was well demonstrated by the
postoperative bronchoscopic examinations, which showed
that the stent would be deformed during vigorous coughing
but would afterward spring back to its original shape. Prob-
lems that have been noted with expandable metal stents
have been excessive granulation tissue formation, sputum
retention, insufficient stent expansion, and difficulty remov-
ing once deployed.22-24 The rate of complications with the
Ultraflex stent as used in the esophagus and the tracheo-
bronchial tree has been noted to be substantially lower than
with other types of stents.19,23
The use of the microvascular flap provides an airtight
lumen and good vascularized tissue for reliable healing. The
only criterion not satisfied is the requirement for a contin-
uous lining with respiratory epithelium for the neotrachea.
A suggested modification to the procedure would be to
deepithelialize the RFFF and seed the dermis with respira-
tory mucosal epithelial cells. The theoretical benefits of
such a lining relate to clearance of secretions using ciliary
action. The absence of mucosal lining may lead to pooling
of secretions and subsequent infection. Initially our patient
was shown on both physical and bronchoscopic examina-
tion to have good clearance of secretions and a vigorous
cough reflex. The patient’s subsequent course was compli-
cated by recurrent pneumonia and several episodes of spu-
tum plugging, 1 episode necessitating intubation. Obtaining
a respiratory mucosal lining may therefore be an important
aim in the long-term success of any tracheal replacement.
Conclusion
Despite a wide range of materials and methods used for
replacing the trachea, a reliable method is still to be found.
Using the RFFF with an Ultraflex stent has some advan-
tages, such as reliability of closure and good healing, as well
as reduced donor site morbidity. There are some problems
with the reconstruction such as stricture formation and lack
of respiratory epithelium. Overall, the RFFF reconstruction
provides a good neotrachea, and future work may prove this
to be a viable technique for reconstructing circumferential
defects of the trachea that are not able to be closed by
primary anastomosis.
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